Início > DPOC / COPD, DR./MD., Principal > Latest News in Copd

Latest News in Copd

7 de junho de 2012

20120607-041757 PM.jpg

Latest News in COPD: Olodaterol

(PulmaoSANews) The COPD patients will count with a new possibility to treat this disease that is popular known as crhonic bronchitis or pulmonary emphisema. The US Boehringer announced that the phase ll study with a drug named olodaterol, a long-acting ß 2-agonist (LABA) showed a significant imcrease in lung function of chronic obstructive pulmonary disease (COPD) patients, delivered via the Respimat ® Inhaler.
What does it really means?
It means that COPD patients will count with another option besides Indacaterol (Onbrize ) to decrease their symptoms and make better their quality of life.
Phase ll Study
In this Phase II randomized, double-blind, cross-over study,
olodaterol administered QD as 5 µg or 10 µg provided a significant and identical increase in the lung function parameter FEV 1 over a 24-hour period. This data completes the olodaterol monotherapy Phase II clinical trial program in patients with COPD.




<img src=

%d blogueiros gostam disto: